| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.61B | 17.24B | 13.14B | 4.00B | 5.89B | 4.14B |
| Gross Profit | 16.90B | 16.50B | 12.50B | 3.60B | 5.55B | 3.93B |
| EBITDA | 3.37B | 3.92B | 1.93B | -4.77B | -2.58B | -2.14B |
| Net Income | -16.60M | 3.20M | -2.01B | -7.80B | -4.14B | -3.02B |
Balance Sheet | ||||||
| Total Assets | 48.94B | 48.72B | 49.74B | 52.65B | 49.91B | 52.72B |
| Cash, Cash Equivalents and Short-Term Investments | 2.37B | 2.21B | 3.54B | 6.86B | 3.20B | 6.13B |
| Total Debt | 28.23B | 27.46B | 29.09B | 32.77B | 23.86B | 20.24B |
| Total Liabilities | 34.92B | 34.55B | 35.65B | 36.63B | 29.50B | 28.08B |
| Stockholders Equity | 13.73B | 13.92B | 13.36B | 16.00B | 20.34B | 24.53B |
Cash Flow | ||||||
| Free Cash Flow | -10.70M | 2.30B | 2.11B | -5.29B | -5.99B | -10.94B |
| Operating Cash Flow | 2.05B | 4.06B | 3.80B | -4.22B | -4.54B | -7.49B |
| Investing Cash Flow | -2.22B | -1.41B | -1.27B | -2.02B | -787.70M | 2.54B |
| Financing Cash Flow | -972.40M | -3.74B | -5.71B | 9.49B | 3.04B | 1.52B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | HK$157.41B | 15.71 | 13.12% | 3.06% | 4.94% | 15.38% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | HK$42.41B | 9.82 | 344.91% | 5.73% | 5.59% | -4.38% | |
61 Neutral | HK$29.79B | 19.06 | -11.87% | 5.92% | -4.41% | -31.45% | |
52 Neutral | HK$138.56B | 22.71 | 71.16% | 2.39% | -3.13% | -13.65% | |
45 Neutral | HK$9.53B | 5.80 | -35.39% | ― | 13.18% | 86.18% | |
40 Neutral | HK$15.13B | -39.90 | -3.15% | ― | 12.29% | 98.20% |